* Ekso Bionics Holdings Inc EKSO.OQ EKSO.O is expected
to show
a rise in quarterly revenue when it reports results on April 29
for the period ending March 31 2024
* The San Rafael California California-based company is
expected
to report a 21.1% increase in revenue to $4.993 million from
$4.12 million a year ago, according to the estimate from one
analyst, based on LSEG data.
* LSEG's mean analyst estimate for Ekso Bionics Holdings
Inc is
for a loss of 16 cents per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Ekso
Bionics
Holdings Inc is $9.25, above its last closing price of $1.28.
This summary was machine generated April 23 at 12:40 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)